ESMO GI 2024 Insights: CodeBreaK 300 - Patient-Reported Tolerability of Sotorasib & Panitumumab vs. Trifluridine/Tipiracil or Regorafenib in mCRC

202 views
July 3, 2024
Comments 0
Login to view comments. Click here to Login